Up next

Autoplay

Progression of Metastatic Pancreatic Cancer

6 Views • 07/30/23
Share
Embed
administrator
administrator
Subscribers
0

George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay